Epidemiological and virological studies of echovirus type 4 meningitis in Japan, 1964. 1968

K Ishii, and Y Matsunaga, and E Onishi, and R Kono

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008587 Meningitis, Viral Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Viral Meningitis,Meningitides, Viral,Viral Meningitides
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002555 Cerebrospinal Fluid A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. Cerebro Spinal Fluid,Cerebro Spinal Fluids,Cerebrospinal Fluids,Fluid, Cerebro Spinal,Fluid, Cerebrospinal,Fluids, Cerebro Spinal,Fluids, Cerebrospinal,Spinal Fluid, Cerebro,Spinal Fluids, Cerebro
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System

Related Publications

K Ishii, and Y Matsunaga, and E Onishi, and R Kono
March 1966, The Journal of hygiene,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
May 2008, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
April 1962, British journal of preventive & social medicine,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
January 1971, Scandinavian journal of infectious diseases,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
May 1964, Lancet (London, England),
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
June 1965, Nihon Shonika Gakkai zasshi. Acta paediatrica Japonica,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
January 1983, Microbiology and immunology,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
January 2008, Revista Argentina de microbiologia,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
October 2003, Pediatric neurology,
K Ishii, and Y Matsunaga, and E Onishi, and R Kono
September 1995, The Pediatric infectious disease journal,
Copied contents to your clipboard!